Japan-based Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy developed by Ionis ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

The company discovered Serine Protease Inhibitors, a class of proteins, which quell inflammation, and Lauder will be researching the proteins’ applications in beauty, as well as other technologies, ...

Researchers at Texas Tech University reviewed how red meat proteins and amino acids affect human health, weighing both ...

Fourth Quarter 2024 Highlights On Dec. 20, 2024, Quoin announced the successful completion of a $6.8 million public offering, bolstering the company’s financial position to support ongoing clinical ...

By taking proactive measures to increase workforce participation, we can empower women to thrive and contribute to a more resilient digital future ...

King Charles appears to be taking a leaf out of his sons’ page as he changes tactic in a surprise move, leaving fans in shock ...

Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...

Assessment of transfer entropy is useful for network analysis of cell signaling network providing information on the network topology and action points of genetic mutations and drug effect, thus will ...

Designing enzymes, unfortunately, is very hard. It’s like working with an atom-sized Lego set, but the instructions are lost ...

The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in ...